Clinical Trial Update: MicroRNA Profiles in Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring microRNA profiles in triple negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: University College Hospital, Ibadan | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN